Delivery Order SPE2DB20D3103-SPE2DB24FL8W1
Award Date 12/12/23
Potential Completion Date 12/13/23
Potential Value $3.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,984,356 units of hydroxychloroquine 200 mg tablets. The contract, valued at $1,539.32, is a firm fixed-price delivery order with an ultimate completion date of August 30, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,632.85 delivery order contract is for the supply of hydroxychloroquine 200 mg tablets. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,610.31 firm fixed price Delivery Order (SPE2DB23FV6G6) is for the supply of 4,560,694,177 units of Hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of April 25, 2023 and does not utilize any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,727.92 firm fixed-price delivery order is for the supply of 4,566,077,675 units of hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of October 11, 2024. This award is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,926.37 firm-fixed-price delivery order is for the supply of 4,559,118,916 units of 200 mg hydroxychloroquine tablets packaged in 100-count bottles. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, with identification number SPE2DB20D3103|SPE2DB22FP9K9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.32 firm fixed-price delivery order is for the supply of 4,558,528,321 units of hydroxychloroquine 200 mg tablets. The contract has a completion date of September 21, 2022 and was awarded on September 20, 2022. Amerisourcebergen, a for-profit...
- This federal contract award for $21,960.00 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200 mg hydroxychloroquine tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing...
- This federal contract award is for the delivery of 4,560,256,895 units of hydroxychloroquine 200 mg tablets, priced at a firm fixed price of $2,766.59. The award was made on March 14, 2023, with a completion date of March 15, 2023, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated with any set-aside requirements, indicating open...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award, worth $2,041.27, is for the supply of 4,560,423,676 units of Hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of March 30, 2023 and is a firm fixed-price arrangement. This award supports the healthcare needs of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Hydroxychloroquine 200 mg, with a contract value of $2,780.34 and a firm fixed price structure. This non-competitive delivery order, issued on December 12, 2025, is due for completion by December 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement from the company's existing Indefinite Delivery...